Compare JXN & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXN | LNTH |
|---|---|---|
| Founded | 1961 | 1956 |
| Country | United States | United States |
| Employees | 3890 | N/A |
| Industry | Life Insurance | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.7B |
| IPO Year | N/A | 2014 |
| Metric | JXN | LNTH |
|---|---|---|
| Price | $133.58 | $100.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $112.40 | $87.00 |
| AVG Volume (30 Days) | 608.7K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.91 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $15.15 | N/A |
| Revenue Next Year | $3.44 | $14.19 |
| P/E Ratio | ★ $16.00 | $34.69 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $89.67 | $49.67 |
| 52 Week High | $137.99 | $111.86 |
| Indicator | JXN | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 45.05 |
| Support Level | $102.95 | $99.22 |
| Resistance Level | N/A | $102.66 |
| Average True Range (ATR) | 3.92 | 2.24 |
| MACD | 0.70 | -0.37 |
| Stochastic Oscillator | 79.81 | 20.53 |
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.